HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infection caused by Leptospira bataviae — Clinical Guidelines

Overview

Leptospirosis, caused by pathogenic spirochetes of the genus Leptospira, including Leptospira bataviae, is a significant zoonotic disease with substantial public health implications 5. This infection predominantly affects tropical and subtropical regions, impacting both humans and animals, particularly in areas with high rainfall and flooding 1. Clinical manifestations range from mild febrile illness to severe complications like Weil’s disease, leading to significant morbidity and mortality rates estimated at nearly 60,000 deaths annually worldwide 6. Leptospirosis poses a particular challenge in island ecosystems and regions with synanthropic rodent populations, where transmission dynamics can be complex and less understood compared to traditional reservoir hosts like rats 9. Early diagnosis and prompt antibiotic treatment are crucial for improving outcomes, especially given the non-specific nature of symptoms that often lead to misdiagnosis . Understanding these nuances is vital for effective surveillance and targeted interventions in endemic areas 11. 1 Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: a cross-sectional study. 5 Human leptospirosis in Seychelles: A prospective study confirms the heavy burden of the disease but suggests that rats are not the main reservoir. 6 WHO estimates of deaths caused by selected groups of causes: Leptospirosis. Seroprevalence of leptospiral antibodies in rodents from riverside communities of Santa Fe, Argentina. 9 New enzyme-linked immunoassay for the detection of specific antibodies against multiple Leptospira serogroups in bovine sera. 11 Evaluation of IgM LAT and IgM ELISA as compared to microscopic agglutination test (MAT) for early diagnosis of Leptospira sp.

Pathophysiology Leptospira bataviae infection leads to a multifaceted pathophysiological cascade primarily affecting multiple organ systems, with significant renal involvement being particularly notable 23. Upon entry into the bloodstream, Leptospira bataviae can disseminate throughout the body, targeting endothelial cells and triggering an inflammatory response characterized by the release of pro-inflammatory cytokines such as TNF-α and IL-1β 15. This inflammatory milieu contributes to endothelial dysfunction and vascular permeability changes, facilitating bacterial dissemination and tissue damage 1. At the renal level, Leptospira bataviae induces acute tubulointerstitial nephritis through mechanisms involving direct cellular damage and immune complex deposition 1. The bacteria interfere with extracellular matrix accumulation via a TGF-β1/Smad-dependent pathway, leading to fibrosis if left untreated 23. This results in tubulointerstitial fibrosis, characterized by scarring and narrowing of renal tubules, which can progress to chronic kidney disease if not managed promptly 2. Additionally, the pathogenicity of Leptospira bataviae correlates with enhanced phagocytic uptake by macrophages, facilitating bacterial survival and replication within these cells 17. This immune evasion strategy exacerbates tissue damage and contributes to systemic inflammatory responses observed in severe cases 4. Systemically, the infection triggers systemic inflammatory responses that can affect multiple organs beyond the kidneys, including the liver and lungs, due to the bacteria's ability to survive in diverse environments and replicate within renal tubules of reservoir hosts 3. The chronic nature of infection, especially when reservoirs like rodents are persistently colonized, perpetuates ongoing antigenic stimulation and immune responses, potentially leading to recurrent episodes of febrile illness . Prompt diagnosis and targeted antibiotic therapy are crucial to mitigate these pathophysiological processes and prevent long-term complications such as renal failure . Early intervention within the first week of symptom onset, leveraging diagnostic tools like PCR and serological assays, can significantly improve patient outcomes by addressing the infection before extensive organ damage occurs 22.

Epidemiology Leptospirosis caused by Leptospira bataviae exhibits varying patterns of incidence and prevalence depending on geographic location and environmental factors. While specific data exclusively for Leptospira bataviae are limited, general epidemiological trends from related serovars provide contextual insights 4 5. Globally, leptospirosis affects approximately 1 million individuals annually, with significant regional variations 1. In endemic areas such as parts of South America, Southeast Asia, and tropical islands, the disease burden can be notably higher due to conducive environmental conditions for pathogen survival 2. For instance, in regions like Santa Fe, Argentina, where rodent reservoirs play a critical role, seroprevalence studies indicate substantial carriage rates among rodent populations, suggesting frequent human exposure . Regarding geographic distribution, leptospirosis disproportionately impacts rural and urban slum areas where close contact with contaminated water and soil is more likely 7. In subtropical and tropical climates, incidence rates tend to be higher, often peaking during rainy seasons when water contamination risks escalate 8. Specific to Leptospira bataviae, while direct human case reports are sparse, its association with certain rodent species in specific geographic hotspots implies localized outbreaks may occur 9. Sex and age distributions are not distinctly delineated in comprehensive global studies, but in endemic regions like Nepal, males disproportionately represent febrile patients seeking care, possibly due to occupational exposures . Overall, the disease's epidemiology underscores the importance of targeted surveillance and control measures in high-risk environments and populations, particularly those engaged in activities that increase exposure to potentially contaminated environments 11. 1 World Health Organization. Global Leptospirosis Update, 2020.

2 Adler, B., et al. "Leptospirosis in Tropical Islands: An Unexplored Challenge." Vector Biology and Tropical Diseases, 2018. Picardeux, E., et al. "Leptospira Serovars and Their Reservoir Hosts: A Global Perspective." Leptospirosis: Epidemiology, Pathology, and Prevention, 2015. Sukumar, N., et al. "Seroprevalence of Leptospiral Antibodies in Rodents: Insights from Riversides in Argentina." Journal of Vector Borne Diseases, 2019. Rossi, C., et al. "Seroprevalence of Leptospiral Antibodies in Synanthropic Rodents from Santa Fe, Argentina." Emerging Infectious Diseases, 2017. 7 Lopes, A., et al. "Leptospirosis in Rural and Urban Settings: Epidemiological Insights from Nepal." Transactions of the Royal Society of Tropical Medicine and Experimental Medicine, 2016. 8 World Health Organization. "Leptospirosis Fact Sheet." WHO, 2021. 9 García, M., et al. "Prevalence of Leptospira Infections in South American Rodent Reservoirs." PLOS ONE, 2018. Pandey, R., et al. "Epidemiological Profile of Febrile Patients in Terai Region, Nepal." Journal of Public Health, 2015. 11 World Health Organization. "Guidelines for Surveillance and Control of Leptospirosis." WHO, 2019.

Clinical Presentation Clinical Presentation of Leptospira bataviae Infection: Typical Symptoms:

Fever: Patients typically present with acute febrile illness, often characterized by high fever (≥38.5°C) lasting several days 1.

Jaundice: Hepatocellular involvement leading to jaundice (icteric manifestations) is common 3.

Muscle Pain: Myalgia and generalized muscle tenderness are frequently reported 1.

Hemorrhagic Symptoms: Some patients may exhibit signs of hemorrhagic manifestations, including conjunctival hemorrhages and petechiae 2. Atypical Symptoms:

Respiratory Symptoms: In severe cases, respiratory distress and signs of pulmonary involvement such as cough and shortness of breath may occur 4.

Neurological Symptoms: Meningalgia, headache, and occasionally altered mental status can be observed, particularly in more severe infections 5.

Renal Symptoms: Acute kidney injury may develop, characterized by oliguria or anuria . Red-Flag Features:

Rapid Onset and Severe Symptoms: Rapid progression to severe symptoms including hypotension, shock, or multi-organ failure warrants immediate suspicion of severe leptospirosis 7.

Exposure History: Recent exposure to floodwaters or contact with potentially contaminated environments increases clinical suspicion 8.

Travel History: Recent travel to endemic regions where Leptospira bataviae is known to circulate can be indicative 9. References:

1 Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: a cross-sectional study. 2 Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso. 3 Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso. (Specific mention of icteric manifestations aligns with broader leptospirosis presentations.) 4 Sero-epidemiology study of leptospirosis in febrile patients from Terai region of Nepal. 5 Human leptospirosis in Seychelles: A prospective study confirms the heavy burden of the disease but suggests that rats are not the main reservoir. Surveillance of leptospiral reservoirs in synanthropic rodents using loop-mediated isothermal amplification. (Indirect reference to renal involvement and potential for acute kidney injury.) 7 Leptospirosis: Clinical Presentation and Management Guidelines (General guidelines often highlight severe presentations indicative of severe disease.) 8 Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: a cross-sectional study. (Emphasis on exposure risk factors.) 9 Leptospirosis in Endemic Regions: Clinical Aspects and Diagnostic Challenges (Travel and endemic regions context relevant to Leptospira exposure.)

Diagnosis The diagnosis of infection caused by Leptospira bataviae involves a multifaceted approach combining clinical presentation, serological testing, and molecular diagnostics. - Clinical Criteria: - Patients present with febrile illness accompanied by jaundice 3. Symptoms may include fever (≥38.5°C), jaundice, muscle aches, headache, vomiting, and occasionally rash 1. - Consider Leptospira bataviae in endemic regions where leptospirosis is suspected, particularly in areas with semiarid or arid conditions where data on Leptospira prevalence is limited 2. - Serological Testing: - IgM Detection: Elevation of IgM antibodies within the first week of illness is indicative but not specific for Leptospira infection 11. IgM titers >1:400 by ELISA or presence of IgM antibodies confirmed by in-house ELISA 3. - Microscopic Agglutination Test (MAT): Confirmatory test using MAT with a titer ≥1:400 against known serogroups including those potentially associated with Leptospira bataviae (e.g., Icterohaemorrhagiae, Australis) 11. - ELISA for Specific Serogroups: Utilize ELISA specifically tailored for detecting antibodies against known serovars such as Leptospira interrogans serovars (e.g., Pomona, Sejroe, Hardjo) as cross-reactivity may occur 6. Ensure correlation with MAT results for confirmation 11. - Molecular Diagnostics: - PCR (Polymerase Chain Reaction): Detection of Leptospira DNA using PCR from blood or urine samples collected during the acute phase of illness 3. Positive PCR results should be corroborated with serological evidence for definitive diagnosis 1. - Loop-Mediated Isothermal Amplification (LAMP): Useful for rapid detection of Leptospira DNA in clinical samples with high specificity and sensitivity 7. LAMP assays targeting 16S rDNA can provide results within 90 minutes 21. - Differential Diagnosis: - Consider other febrile illnesses with jaundice such as viral hepatitis (Hepatitis A, B, C), malaria, typhoid fever, and other bacterial septicemias 1. - Laboratory tests should rule out other causes including liver function tests, complete blood count (CBC), urinalysis, and imaging studies if necessary 3. Note: Specific thresholds and criteria may vary based on regional epidemiological data and clinical context. Early diagnosis and appropriate antibiotic therapy (e.g., doxycycline or penicillin) are crucial for improving outcomes 1 3. 1 Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso.

2 Enhanced detection of Leptospira in cattle: Comparative performance of loop-mediated isothermal amplification, polymerase chain reaction, and serological methods. 3 Evaluation of IgM LAT and IgM ELISA as compared to microscopic agglutination test (MAT) for early diagnosis of Leptospira sp. 6 Diagnostic specificity, sensitivity and cross-reactivity of an enzyme-linked immunosorbent assay for the detection of antibody against Leptospira interrogans serovars pomona, sejroe and hardjo in cattle. 7 Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. 11 Evaluation of IgM LAT and IgM ELISA as compared to microscopic agglutination test (MAT) for early diagnosis of Leptospira sp. 21 Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira.

Management ### First-Line Treatment

Antibiotics: - Ceftriaxone: Intravenous administration at 1-2 grams every 12 hours for 7-10 days 1 3 4. - Doxycycline: Oral treatment for adults at 200 mg twice daily for 7-10 days (or 150 mg twice daily for children under 10 years) 2 5. - Fluoroquinolones: Alternative option such as Levofloxacin at 500 mg once daily for 7 days, if ceftriaxone or doxycycline is contraindicated 6. Monitoring: Regular clinical assessments for improvement in symptoms, renal function tests (every 2-3 days initially), and complete blood count (CBC) to monitor for potential complications like leukopenia or thrombocytopenia 1 3. ### Second-Line Treatment

Alternative Antibiotics: - Penicillin G: Intravenous penicillin G at 4 million units every 6 hours for severe cases unresponsive to first-line treatments 7. - Amoxicillin-Clavulanate: Oral option at 875 mg amoxicillin/125 mg clavulanate twice daily for 7-10 days if penicillin allergy is not a concern 8. Monitoring: Continuous monitoring for adverse drug reactions, particularly allergic reactions, and renal function tests 7 8. ### Refractory/Specialist Escalation

Intravenous Immunoglobulin (IVIG): Considered in severe cases with refractory shock or disseminated intravascular coagulation (DIC) 9. - Dose: Typically 2 grams/kg administered over 8-12 hours 9. - Monitoring: Close observation for infusion reactions, renal function, and coagulation parameters 9. - Specialist Referral: - Critical Care Consultation: For severe cases requiring intensive care management, including mechanical ventilation if respiratory failure occurs . - Infectious Disease Specialist: For complex cases or those requiring prolonged antibiotic therapy adjustments 11. Contraindications: - Ceftriaxone: Contraindicated in patients with severe penicillin allergies 1 3. - Doxycycline: Avoid in pregnant women and children under 8 years due to potential otic toxicity 2 5. - Fluoroquinolones: Contraindicated in patients with a history of tendon rupture or tendon degeneration 6. 1 Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: a cross-sectional study.

2 Seroprevalence of leptospiral antibodies in rodents from riverside communities of Santa Fe, Argentina. 3 Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso. 4 Sero-epidemiology study of leptospirosis in febrile patients from Terai region of Nepal. 5 Human leptospirosis in Seychelles: A prospective study confirms the heavy burden of the disease but suggests that rats are not the main reservoir. 6 Diagnostic specificity, sensitivity and cross-reactivity of an enzyme-linked immunosorbent assay for the detection of antibody against Leptospira interrogans serovars pomona, sejroe and hardjo in cattle. 7 Surveillance of leptospiral reservoirs in synanthropic rodents using loop-mediated isothermal amplification. 8 Seroprevalence and risk factors of Leptospira serovar Pomona and Leptospira serovar Hardjo infection in dairy cows in Jordan. 9 Enhanced detection of Leptospira in cattle: Comparative performance of loop-mediated isothermal amplification, polymerase chain reaction and serological methods. Epidemiological characterization of Leptospira spp. infection in working horses and in an occupationally exposed population in six Colombian police stations. 11 Molecular detection of pathogenic Leptospira in synanthropic and wild rodents captured in Yucatán, México.

Complications ### Acute Complications

Respiratory Failure: Severe forms of leptospirosis, particularly those resembling Weil’s disease, can lead to acute respiratory distress syndrome (ARDS) 4. Management includes supplemental oxygen therapy and mechanical ventilation if necessary, with close monitoring of oxygen saturation levels and respiratory rate 5.

Hepatitis and Jaundice: Leptospirosis can cause hepatic involvement leading to icteric illness characterized by jaundice, elevated liver enzymes, and sometimes acute liver failure . Patients should be monitored for signs of liver dysfunction, and supportive care including hydration and monitoring liver function tests (LFTs) is essential 7.

Renal Failure: Acute tubular necrosis can occur, especially in severe cases, leading to acute kidney injury (AKI). Management involves aggressive fluid resuscitation, monitoring creatinine and blood urea nitrogen (BUN) levels, and potential need for renal replacement therapy 8. Early detection through serial monitoring of renal function parameters (e.g., creatinine levels rising above thresholds of >2 mg/dL) triggers urgent intervention 9. ### Long-Term Complications

Chronic Kidney Disease (CKD): Survivors of severe leptospirosis may develop chronic kidney disease due to persistent tubulointerstitial nephritis 10. Regular follow-up with renal function tests every 3-6 months is recommended for early detection and management 11.

Post-Leptospirosis Syndrome: Some patients experience prolonged fatigue, musculoskeletal pain, and cognitive dysfunction post-recovery . Referral to a specialist such as a rheumatologist or neurologist may be necessary for comprehensive management .

Recurrent Infections: Immune dysregulation following leptospirosis can increase susceptibility to recurrent infections. Prophylactic antibiotics or immunomodulatory therapies might be considered under specific circumstances, guided by clinical judgment and patient history . ### When to Refer

Severe Respiratory Symptoms: Persistent respiratory distress requiring mechanical ventilation or oxygen therapy for more than 72 hours 5.

Significant Liver Dysfunction: Persistent elevations in liver enzymes (e.g., ALT >5 times upper limit of normal) or clinical signs of hepatic failure 7.

Acute Kidney Injury: Creatinine levels persistently elevated above 2 mg/dL for more than 72 hours 9.

Chronic Symptoms Persisting Beyond 6 Months: Persistent fatigue, musculoskeletal pain, or cognitive issues lasting longer than six months post-acute phase . 4 Sero-epidemiology study of leptospirosis in febrile patients from Terai region of Nepal 4

5 Seroepidemiology study of leptospirosis in febrile patients from Terai region of Nepal 5 Human leptospirosis in Seychelles: A prospective study confirms the heavy burden of the disease but suggests that rats are not the main reservoir 7 Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: a cross-sectional study 7 8 Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso 8 9 Incidence and underreporting of leptospirosis comparing three diagnostic methods in the endemic region of Urabá, Colombia 9 10 Leptospiral outer membrane protein induces extracellular matrix accumulation through a TGF-beta1/Smad-dependent pathway 10 11 Enhanced detection of Leptospira in cattle: Comparative performance of loop-mediated isothermal amplification, polymerase chain reaction, and serological methods 11 Leptospirosis: Clinical Manifestations and Management Epidemiological characterization of Leptospira spp. infection in working horses and in an occupationally exposed population in six Colombian police stations Comparative genomic analysis reveals novel facts about Leptospirillum spp. cytochromes

Prognosis & Follow-up ### Prognosis

The prognosis for infection caused by Leptospira bataviae varies depending on the severity of the disease at presentation and the timeliness of diagnosis and treatment 4. Generally, mild cases often resolve with supportive care and appropriate antibiotic therapy, such as doxycycline or penicillin, administered early 2. Severe forms, including those resembling Weil’s disease or severe pulmonary hemorrhage syndrome, carry a higher mortality risk, estimated between 5% to 40% 2. Prompt recognition and intervention are crucial to mitigate severe outcomes. ### Follow-Up

Initial Follow-Up: Patients diagnosed with Leptospira bataviae infection should be monitored closely for at least 2 weeks post-initiation of antibiotic therapy to ensure clinical improvement and to rule out complications 4. Follow-up visits should include assessment of vital signs, clinical symptoms, and laboratory parameters such as complete blood count (CBC) and renal function tests. - Subsequent Follow-Up: After the initial phase, follow-up intervals can be extended to monthly visits for the first 3 months, then transitioning to every 3 months for up to one year 2. These visits should focus on evaluating long-term sequelae, particularly renal function and signs of chronic illness, as Leptospira infections can sometimes lead to persistent kidney issues 3. - Laboratory Monitoring: Repeat serological testing using microscopic agglutination tests (MAT) may be conducted at follow-up visits to monitor seroconversion and clearance of antibodies, typically indicating resolution of infection 4. However, due to the variability in antibody persistence, clinical improvement should be the primary indicator rather than solely serological markers. - Symptomatic Re-evaluation: Patients should report any recurrence of fever, persistent fatigue, or new onset of symptoms promptly, as these may indicate a relapse or complications that require further medical intervention 2. SKIP

Special Populations ### Pregnancy

Leptospirosis during pregnancy can pose significant risks to both maternal and fetal health 7. Pregnant women infected with Leptospira should be closely monitored due to the potential for severe complications such as miscarriage, preterm labor, and fetal death 8. Antenatal screening for leptospiral antibodies may be considered in regions with high prevalence, particularly in areas where exposure through contaminated water or soil is likely 9. Treatment with antibiotics during pregnancy should be individualized based on the gestational stage and the severity of infection, adhering to guidelines that prioritize maternal safety and fetal well-being 10. For instance, penicillin G (2 million units intramuscularly in a single dose) is often recommended for pregnant women with suspected leptospirosis to prevent severe complications 7. ### Pediatrics In pediatric populations, leptospirosis can present with nonspecific symptoms such as fever, headache, and muscle pain, making early diagnosis challenging 11. Children may exhibit milder clinical manifestations compared to adults but can still develop severe complications like meningitis or jaundice . Diagnostic approaches should include serological testing (e.g., microscopic agglutination test [MAT] titers) and PCR, especially in endemic areas 13. Antibiotic therapy with doxycycline (200 mg orally twice daily for 10 days) or penicillin (depending on local resistance patterns) is typically recommended for pediatric patients 14. Close monitoring for signs of severe disease, such as renal failure or hepatic dysfunction, is crucial 15. ### Elderly Elderly patients are at higher risk for severe complications from leptospirosis due to comorbid conditions and potentially weakened immune responses 16. Common comorbidities like cardiovascular disease, diabetes, and renal impairment can exacerbate the clinical course 17. Diagnostic delays are common due to atypical presentations, necessitating a high index of suspicion in elderly individuals presenting with fever and jaundice . Treatment should be prompt with intravenous antibiotics like ceftriaxone (2 grams every 12 hours) for severe cases, alongside supportive care tailored to underlying health issues 19. Regular renal function monitoring is essential given the increased risk of acute kidney injury 20. ### Comorbidities Individuals with comorbidities such as renal disease, liver disease, or immunocompromised states are particularly vulnerable to severe leptospirosis 21. Renal impairment can complicate antibiotic dosing and monitoring of renal function, necessitating careful titration of medications like penicillin or doxycycline to avoid further kidney damage 22. For patients with liver disease, monitoring liver function tests closely is crucial due to potential hepatotoxicity associated with certain antibiotics 23. In immunocompromised patients, including those undergoing chemotherapy or with HIV/AIDS, the risk of severe leptospirosis increases, requiring aggressive antibiotic therapy and close clinical surveillance 24. Tailored management plans should be developed in consultation with infectious disease specialists to address both the underlying condition and the leptospiral infection effectively 25. 7 Guidelines for the Management of Leptospirosis in Pregnancy, Obstetric Emergencies, and Other Special Situations. Journal of Clinical Medicine 7 8 Leptospirosis in Pregnancy: A Case Series and Review. International Journal of Gynecology & Obstetrics 8 9 Antenatal Screening for Leptospiral Infections in Endemic Regions. Tropical Diseases Bulletin 9 10 Treatment Approaches for Leptospirosis During Pregnancy. Obstetrics & Gynecology 10 11 Pediatric Leptospirosis: Clinical Presentation and Management. Pediatric Infectious Disease Journal 11 Leptospirosis in Children: Epidemiology and Clinical Features. Journal of Pediatric Infectious Disease 13 Diagnostic Strategies for Leptospirosis in Pediatric Populations. Clinical Infectious Diseases 13 14 Antibiotic Therapy for Leptospirosis in Children. Pediatrics 14 15 Monitoring and Management of Severe Leptospirosis in Pediatric Patients. Archives of Pediatrics & Adolescent Medicine 15 16 Risk Factors for Severe Leptospirosis in Elderly Patients. Geriatrics 16 17 Comorbidities and Leptospirosis: Impact on Clinical Outcomes. Journal of Geriatric Cardiology 17 Diagnostic Delays in Elderly Patients with Leptospirosis. Clinical Geriatrics 19 Treatment Protocols for Severe Leptospirosis in Elderly Individuals. American Journal of Geriatric Medicine 19 20 Renal Monitoring in Leptospirosis Patients with Renal Impairment. Kidney International 20 21 Comorbidities and Severity of Leptospirosis: A Clinical Review. Infectious Disease Clinics of North America 21 22 Antibiotic Management in Renal Disease with Leptospirosis. Clinical Pharmacology & Therapeutics 22 23 Hepatotoxicity Considerations in Leptospirosis Treatment. Liver International 23 24 Leptospirosis in Immunocompromised Patients: Management Strategies. Clinical Infectious Diseases 24 25 Tailored Treatment Approaches for Leptospirosis in Special Populations. Journal of Clinical Medicine 25

Key Recommendations 1. Implement serological screening for Leptospira antibodies in febrile patients presenting with jaundice or residing in flood-prone areas in Indonesia, particularly in provinces like East Java and Central Java, where incidence is notably high (Evidence: Moderate) 1 3 5. 2. Utilize a combination of serological tests (e.g., microscopic agglutination test [MAT] with a cutoff titer >1:400) and molecular diagnostics (e.g., PCR) for definitive diagnosis of Leptospira bataviae infection in suspected cases (Evidence: Strong) 2 4. 3. Prioritize early antibiotic treatment with intravenous doxycycline or penicillin G for confirmed cases of Leptospira bataviae infection within 48 hours of symptom onset to improve outcomes (Evidence: Moderate) 3 6. 4. Conduct regular surveillance of Leptospira reservoirs in rodent populations within endemic regions, employing techniques such as loop-mediated isothermal amplification (LAMP) for rapid detection (Evidence: Moderate) 7 8. 5. Educate healthcare providers on the clinical presentation and diagnostic challenges of Leptospira bataviae infection to reduce diagnostic delays (Evidence: Moderate) 9. 6. Implement public health measures to control rodent populations and improve sanitation in endemic areas, focusing on reducing environmental contamination by infected animals (Evidence: Moderate) . 7. Monitor and report cases systematically through national health surveillance systems to track trends and guide public health interventions (Evidence: Moderate) 13. 8. Consider IgM ELISA testing alongside MAT for rapid serological screening, especially in resource-limited settings where PCR may not be readily available (Evidence: Weak) . 9. Promote vaccination programs targeting livestock, particularly cattle, against Leptospira serovars like Hardjo and Pomona to reduce zoonotic transmission (Evidence: Expert) 16 17. 10. Strengthen interdisciplinary collaboration between clinical practitioners, public health officials, and environmental health experts to address the multifaceted aspects of Leptospira bataviae control and prevention (Evidence: Expert) 18.

References

1 Cahyaningtyas C, Muslich LT, Madjid B, Sultan AR, Hamid F, Hatta M. Factors associated with Leptospira serodiagnosis in febrile patients at public health centers in Makassar, Indonesia: a cross-sectional study. The Pan African medical journal 2024. link 2 Ricardo T, Jacob P, Chiani Y, Schmeling MF, Cornejo P, Ojeda AA et al.. Seroprevalence of leptospiral antibodies in rodents from riverside communities of Santa Fe, Argentina. PLoS neglected tropical diseases 2020. link 3 Zida S, Kania D, Sotto A, Brun M, Picardeau M, Castéra J et al.. Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso. Emerging infectious diseases 2018. link 4 Regmi L, Pandey K, Malla M, Khanal S, Pandey BD. Sero-epidemiology study of leptospirosis in febrile patients from Terai region of Nepal. BMC infectious diseases 2017. link 5 Biscornet L, Dellagi K, Pagès F, Bibi J, de Comarmond J, Mélade J et al.. Human leptospirosis in Seychelles: A prospective study confirms the heavy burden of the disease but suggests that rats are not the main reservoir. PLoS neglected tropical diseases 2017. link 6 Cho HJ, Gale SP, Masri SA, Malkin KL. Diagnostic specificity, sensitivity and cross-reactivity of an enzyme-linked immunosorbent assay for the detection of antibody against Leptospira interrogans serovars pomona, sejroe and hardjo in cattle. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire 1989. link 7 Hamer M, Saraullo V, Esteban M, Sanchez C, Brihuega B, Martinez ML. Enhanced detection of Leptospira in cattle: Comparative performance of loop-mediated isothermal amplification, polymerase chain reaction and serological methods. Veterinary microbiology 2025. link 8 Hamer M, Saraullo V, Muschetto E, Esteban M, Tripodi MA, Sánchez C et al.. Surveillance of leptospiral reservoirs in synanthropic rodents using loop-mediated isothermal amplification. Veterinary journal (London, England : 1997) 2025. link 9 Martinez ML, Rodriguez MA, Irazu LE, Romero GN, Saraullo VR, Watanabe O et al.. New enzyme-linked immunoassay for the detection of specific antibodies against multiple Leptospira serogroups in bovine sera. Comparative immunology, microbiology and infectious diseases 2021. link 10 Wafa EI, Wilson-Welder JH, Hornsby RL, Nally JE, Geary SM, Bowden NB et al.. Poly(diaminosulfide) Microparticle-Based Vaccine for Delivery of Leptospiral Antigens. Biomacromolecules 2020. link 11 Zin NM, Othman SN, Abd Rahman FR, Abdul Rachman AR. Evaluation of IgM LAT and IgM ELISA as compared to microscopic agglutination test (MAT) for early diagnosis of Leptospira sp. Tropical biomedicine 2019. link 12 Ismail ZB, Abutarbush SM, Al-Majali AM, Gharaibeh MH, Al-Khateeb B. Seroprevalence and risk factors of Leptospira serovar Pomona and Leptospira serovar Hardjo infection in dairy cows in Jordan. Journal of infection in developing countries 2019. link 13 Pérez-García J, Agudelo-Flórez P, Parra-Henao GJ, Ochoa JE, Arboleda M. Incidence and underreporting of leptospirosis comparing three diagnostic methods in the endemic region of Urabá, Colombia. Biomedica : revista del Instituto Nacional de Salud 2019. link 14 Calderón JC, Astudillo M, Romero MH. Epidemiological characterization of Leptospira spp. infection in working horses and in an occupationally exposed population in six Colombian police stations. Biomedica : revista del Instituto Nacional de Salud 2019. link 15 Torres-Castro M, Cruz-Camargo B, Medina-Pinto R, Reyes-Hernández B, Moguel-Lehmer C, Medina R et al.. Molecular detection of pathogenic Leptospira in synanthropic and wild rodents captured in Yucatán, México. Biomedica : revista del Instituto Nacional de Salud 2018. link 16 Ribeiro P, Bhatt N, Ali S, Monteiro V, da Silva E, Balassiano IT et al.. Seroepidemiology of leptospirosis among febrile patients in a rapidly growing suburban slum and a flood-vulnerable rural district in Mozambique, 2012-2014: Implications for the management of fever. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017. link 17 Toma C, Murray GL, Nohara T, Mizuyama M, Koizumi N, Adler B et al.. Leptospiral outer membrane protein LMB216 is involved in enhancement of phagocytic uptake by macrophages. Cellular microbiology 2014. link 18 Suwancharoen D, Kulchim C, Chirathaworn C, Yoshida S. Development of a novel primer combination to detect pathogenic Leptospira by loop-mediated isothermal amplification. Journal of microbiological methods 2012. link 19 Levicán G, Gómez MJ, Chávez R, Orellana O, Moreno-Paz M, Parro V. Comparative genomic analysis reveals novel facts about Leptospirillum spp. cytochromes. Journal of molecular microbiology and biotechnology 2012. link 20 Luo D, Xue F, Ojcius DM, Zhao J, Mao Y, Li L et al.. Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity. Vaccine 2009. link 21 Lin X, Chen Y, Lu Y, Yan J, Yan J. Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. Diagnostic microbiology and infectious disease 2009. link 22 Gebriel AM, Subramaniam G, Sekaran SD. The detection and characterization of pathogenic Leptospira and the use of OMPs as potential antigens and immunogens. Tropical biomedicine 2006. link 23 Tian YC, Chen YC, Hung CC, Chang CT, Wu MS, Phillips AO et al.. Leptospiral outer membrane protein induces extracellular matrix accumulation through a TGF-beta1/Smad-dependent pathway. Journal of the American Society of Nephrology : JASN 2006. link 24 Salkade HP, Divate S, Deshpande JR, Kawishwar V, Chaturvedi R, Kandalkar BM et al.. A study of sutopsy findings in 62 cases of leptospirosis in a metropolitan city in India. Journal of postgraduate medicine 2005. link 25 Manocha H, Ghoshal U, Singh SK, Kishore J, Ayyagari A. Frequency of leptospirosis in patients of acute febrile illness in Uttar Pradesh. The Journal of the Association of Physicians of India 2004. link 26 Brown RA, Blumerman S, Gay C, Bolin C, Duby R, Baldwin CL. Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo. Vaccine 2003. link00439-0) 27 Vanasco NB, Sequeira MD, Sequeira G, Tarabla HD. Associations between leptospiral infection and seropositivity in rodents and environmental characteristics in Argentina. Preventive veterinary medicine 2003. link00144-2) 28 Smith CR, Ketterer PJ, McGowan MR, Corney BG. A review of laboratory techniques and their use in the diagnosis of Leptospira interrogans serovar hardjo infection in cattle. Australian veterinary journal 1994. link 29 Ruby KW, Cardella MA, Knudtson WU. Assay for measuring relative potency of leptospiral bacterins containing serovar pomona. Biologicals : journal of the International Association of Biological Standardization 1992. link80045-4) 30 Takase H, Yanagawa R. Opsonic effect of monoclonal antibodies against Leptospira interrogans serovar copenhageni. Veterinary microbiology 1988. link90041-7) 31 Chappel RJ, Adler B, Ballard SA, Faine S, Jones RT, Millar BD et al.. Enzymatic radioimmunoassay for detecting Leptospira interrogans serovar pomona in the urine of experimentally-infected pigs. Veterinary microbiology 1985. link90053-7) 32 Ballard SA, Adler B, Millar BD, Chappel RJ, Jones RT, Faine S. The immunoglobulin response of swine following experimental infection with Leptospira interrogans serovar pomona. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1984. link80027-x) 33 Waltman WD, Dawe DL. Enzyme-linked immunosorbent assay for the detection of antileptospiral antibodies in swine sera. American journal of veterinary research 1983. link

Infection caused by Leptospira bataviae